Insider trade

Elevance Health (ELV)Director bought ~$870K

Steven H Collis, Director at Elevance Health, bought ~$870K of Elevance Health shares.

~$870K
Approx. value · 3,000 sh @ $289.84: 3,639
Holds after · shares reported

Traded: Mar 5, 2026
Filed: Mar 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Dec 29, 2025CongressDisclosed purchase of ELV — reported range $15,001 - $50,000
Jan 28, 2026Company filing · Form 8-K · ResultsReported its results
Feb 26, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On February 26, 2026, Elevance Health, Inc. (the “Company”) announced certain management changes. Among these changes, Peter D. Haytaian will transition from his role as Executive Vice President and President of Carelon, effective May 4, 2026, to devote more time to family commitments.”
Mar 5, 2026 · this disclosureInsider · Their first buy on recordDirector purchased ~$870K of ELV shares in the open market

What came next

Mar 6, 2026InsiderOfficer sold ~$911K of ELV shares in the open market
Mar 12, 2026InsiderDirector sold ~$7.5K of ELV shares in the open market
Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
Apr 22, 2026Company filing · Form 8-K · ResultsReported its results
Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.1%
May 19, 2026InsiderOfficer sold ~$617K of ELV shares in the open market
Jun 11, 2026InsiderDirector sold ~$61K of ELV shares in the open market
Jun 12, 2026InsiderOfficer sold ~$149K of ELV shares in the open market

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Elevance Health

For Elevance Health, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 37 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ELV page.

Other recent filings by Steven H Collis, Director

The full history of Steven H Collis, Director is on the profile page.

How this filing works

Other disclosures at Elevance Health

Everything OQRO holds on this company is on its ELV page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data